colon cancer
Overview of Colorectal Cancer (CRC)
Colorectal Cancer (CRC): Most common in the lining of the large bowel, primarily arising from polyps.
Significance: Second leading cause of cancer-related deaths in Australia, with approximately 3,999 fatalities annually.
Early Detection: Over 90% survival rate over 5 years if diagnosed early.
Cancer Development and Characteristics
Multi-step Process
Cancer Development: Driven by mutation accumulation over time.
Tumor Development: Begins with benign adenoma progressing to malignant adenocarcinoma.
Tumors: Defined as clusters of abnormal cells growing faster than normal cells.
Tumor Types
Benign Tumors: Clustered cells with similar characteristics to originating tissue, generally non-invasive.
Malignant Tumors: Have the ability to invade surrounding tissues and metastasize.
Hallmarks of Cancer
Phenotypic Changes in Tumor Cells
Distinguishing Features:
Loss of contact inhibition.
Production of their own growth factors.
Survival without contact.
Genetic Mutations and Accumulation
DNA Mutations: Inevitable over a lifetime, due to a high number of cell divisions (approximately 10^16) and spontaneous mutation rates (10^10 mutations per gene).
Multiple Rounds of Mutation: Required for progression to cancer, with natural selection favoring the most malignant clones.
Types of Mutations
DNA Damage Pathways
Causes of Mutations:
Radiation/UV damage, chemical carcinogens (e.g., smoking), stress (reactive oxygen species), pathogens (e.g., viruses), and inherited mutations.
Changes in DNA and Their Effects
Missense Mutation: Alters an amino acid, potentially changing protein function.
Nonsense Mutation: Alters a stop codon, truncating the protein.
Frameshift Mutation: Changes coding sequences by adding or removing bases.
Gene Deletion or Amplification: Changes in protein function or overexpression (e.g., growth factors).
Chromosomal Translocations: Formation of fusion proteins or oncogenes under strong promoters.
Genetic Instability and Cancer
Optimal Genetic Instability: Required for cancer development; promotes mutation accumulation, leading to functional impairments.
Somatic vs Germline Mutations:
Somatic mutations (non-heritable) vs. germline mutations (heritable) are pivotal in cancer progression.
Major Mutational Syndromes
Familial Adenomatous Polyposis (FAP): Characterized by numerous polyps and a high likelihood of cancer if untreated (APC gene mutation).
Hereditary Non-polyposis Colon Cancer (HNPCC/Lynch Syndrome): Associated with mismatch repair gene defects, results in high cancer risk, particularly in the right colon.
Pathways Leading to Colon Cancer
Key Genes and Pathways
APC, K-ras, P53, SMAD4: Mutations in these genes lead to tumor development and progression.
Mismatch Repair System
Function: Detects and repairs DNA errors. Deficiencies lead to microsatellite instability (MSI), contributing to colorectal cancer.
Tyrosine Kinase Signaling
Role in Cancer: Mutations activate signaling pathways that promote cell proliferation and inhibit apoptosis.
Key Players: Proto-oncogenes (e.g., Ras) and tumor suppressor genes (e.g., PTEN).
Metastasis
Mechanism: Involves changes in cancer cells that allow them to migrate from the primary tumor site through the lymphatic system to establish secondary tumors.
Epithelial to Mesenchymal Transition (EMT): Required for movement and invasion during metastasis.
Loss of E-cadherin: Contributes to cell detachment and migration, facilitating metastasis.
Summary of Colon Cancer Mechanisms
Progression: Cancer develops through successive mutations and genetic instability, leading to various modifications in cellular behavior and characteristics, fundamentally altering cell functions.